|
2024
|
Invention
|
Bispecific t cell activating antigen binding molecules.
The present invention generally relates ... |
|
2023
|
Invention
|
Antigen binding molecules with increased fc receptor binding affinity and effector function.
The... |
|
|
Invention
|
Antibody fc variants.
The invention relates to engineered nolyneptides comprising Fc variants an... |
|
|
Invention
|
Anti-cea antibodies.
The present invention provides antigen binding molecules (ABMs) which bind ... |
|
2022
|
Invention
|
Anti-fap antibodies and methods of use.
The invention provides antibodies against Fibroblast Act... |
|
2021
|
Invention
|
Novel immunoconjugates.
The present invention generally relates to antigen-specific immunoconjug... |
|
2020
|
Invention
|
Aspgr antibodies and uses thereof.
The present invention generally relates to antibodies specifi... |
|
|
Invention
|
Antibody fc variants.
The invention relates to engineered polypeptides comprising Fc variants an... |
|
|
Invention
|
Bispecific anti-vegf/anti-ang-2 antibodies and their use in the treatment of ocular vascular dise... |
|
|
Invention
|
Combination il-2 immunoconjugate therapy.
The present invention provides combinations of (a) an ... |
|
|
Invention
|
Interleukin-2 fusion proteins and uses thereof. The present invention generally relates to fusion... |
|
2019
|
Invention
|
Antigen binding molecules that bind egfr, vectors encoding same, and uses thereof.
The present i... |
|
|
Invention
|
Mutant interleukin-2 polypeptides.
The present invention generally relates to mutant interleukin... |
|
|
Invention
|
Immunoconjugates. The present invention generally relates to antigen-specific immunoconjugates fo... |
|
|
Invention
|
Anti-fap antibodies and methods of use. The invention provides antibodies against Fibroblast Acti... |
|
2018
|
Invention
|
Mutant interleukin-2 polypeptides. The present invention generally relates to mutant interleukin-... |
|
|
Invention
|
Bispecific t cell activating antigen binding molecules. The present invention generally relates t... |
|
|
Invention
|
Removal of cancer cells by circulating virus-specific cytotoxic t-cells using cancer cell targete... |
|
|
Invention
|
Separation method for fucosylated antibodies.
The present invention relates to a method for the ... |
|
|
Invention
|
Antibodies specific for dr5 and methods of use. The present invention relates to bispecific antib... |
|
2017
|
Invention
|
Aspgr antibodies and uses thereof. The present invention generally relates to antibodies specific... |
|
|
Invention
|
Anti-her3 antibodies and uses thereof. The present invention relates to antibodies binding to hum... |
|
2016
|
Invention
|
Combination il-2 immunoconjugate therapy. The present invention provides combinations of (a) an i... |
|
|
Invention
|
Bispecific antigen binding molecules.
The present invention generally relates to novel bispecifi... |
|
|
Invention
|
A-fucosylation detection in antibodies. This invention describes a new analytical method to deter... |
|
|
Invention
|
Interleukin-10 fusion proteins and uses thereof. The present invention generally relates to fusio... |
|
2015
|
Invention
|
Method and constructs for the ph dependent passage of the blood-brain-barrier.
Herein is reporte... |
